Literature DB >> 24810657

Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy.

Sophie Hurel1, Morgan Rouprêt, Thomas Seisen, Eva Comperat, Véronique Phé, Stéphane Droupy, François Audenet, Géraldine Pignot, Xavier Cathelineau, Laurent Guy, Olivier Cussenot, Adil Ouzzane, Gregory Bozzini, Laurent Nison, Alain Ruffion, Pierre Colin.   

Abstract

PURPOSE: To evaluate the influence of preoperative factors on the survival of patients diagnosed with upper tract urothelial carcinoma (UTUC) who underwent a radical nephroureterectomy (RNU).
METHODS: A multicentre retrospective study was performed on all patients with UTUC who underwent a RNU. Multiple preoperative criteria were tested as prognostic factors for cancer-specific survival (CSS) using univariate and multivariable Cox regression analyses.
RESULTS: Overall, 476 patients with a median age of 69.2 (IQR 60.8-76.5) years were included. The median follow-up was 27.8 months (IQR 10.5-49.3). At the time of diagnosis, 400 (84.1 %) patients presented with symptoms and 76 patients (15.9 %) were asymptomatic. Renal failure, altered general health, a preoperative locally advanced tumour and multifocal disease appeared to be preoperative prognostic factors for CSS (p = 0.01, 0.03, 0.001 and 0.03, respectively) in the univariate analysis. Only renal failure (p = 0.03), a preoperative locally advanced tumour (0.004), and multifocal locations (p = 0.01) were confirmed as independent factors of CSS in the multivariate analysis. The independent prognosticators of definitive muscle-invasive stage and non-organ-confined disease were preoperative renal failure (p = 0.02, 0.027, respectively), locally advanced stage (p < 0.001, <0.001, respectively) and positive cytology (p = 0.006, 0.003 respectively). Female gender was independent factor only for prediction of final non-organ-confined disease (p = 0.007). The addition of these parameters in our preoperative complex model permitted the prediction of muscle-invasive or locally advanced disease in 65.3 and 67.2 % of patients, respectively.
CONCLUSIONS: Patients with preoperative impaired renal function, locally advanced stage and multifocal tumours before RNU had worse survival outcomes compared to other patients.

Entities:  

Mesh:

Year:  2014        PMID: 24810657     DOI: 10.1007/s00345-014-1311-8

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  24 in total

1.  Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.

Authors:  Ricardo L Favaretto; Shahrokh F Shariat; Caroline Savage; Guilherme Godoy; Daher C Chade; Matthew Kaag; Bernard H Bochner; Jonathan Coleman; Guido Dalbagni
Journal:  BJU Int       Date:  2011-06-01       Impact factor: 5.588

2.  Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy.

Authors:  Keiichi Ito; Kenji Kuroda; Junichi Asakuma; Shinsuke Hamada; Kazuyoshi Tachi; Shinsuke Tasaki; Akinori Sato; Akio Horiguchi; Kenji Seguchi; Tomohiko Asano
Journal:  J Urol       Date:  2014-01-11       Impact factor: 7.450

3.  Incidence and survival of rare urogenital cancers in Europe.

Authors:  O Visser; J Adolfsson; S Rossi; J Verne; G Gatta; M Maffezzini; K N Franks
Journal:  Eur J Cancer       Date:  2011-11-24       Impact factor: 9.162

4.  European guidelines on upper tract urothelial carcinomas: 2013 update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-03-19       Impact factor: 20.096

5.  Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.

Authors:  Brian R Lane; Armine K Smith; Benjamin T Larson; Michael C Gong; Steven C Campbell; Derek Raghavan; Robert Dreicer; Donna E Hansel; Andrew J Stephenson
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

6.  Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005.

Authors:  Jay D Raman; Jamie Messer; John A Sielatycki; Christopher S Hollenbeak
Journal:  BJU Int       Date:  2010-09-03       Impact factor: 5.588

7.  Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.

Authors:  Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Lars Budäus; Mathieu Latour; Hugues Widmer; Alain Duclos; Francois Bénard; Michael McCormack; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Urology       Date:  2009-12-04       Impact factor: 2.649

8.  Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature.

Authors:  Laura-Maria Krabbe; Mary E Westerman; Aditya Bagrodia; Bishoy A Gayed; Dina Khalil; Payal Kapur; Shahrokh F Shariat; Ganesh V Raj; Arthur I Sagalowsky; Jeffrey A Cadeddu; Yair Lotan; Vitaly Margulis
Journal:  Urol Oncol       Date:  2014-01       Impact factor: 3.498

Review 9.  Laser therapy for upper urinary tract transitional cell carcinoma: indications and management.

Authors:  Markus J Bader; Ronald Sroka; Christian Gratzke; Michael Seitz; Patrick Weidlich; Michael Staehler; Armin Becker; Christian G Stief; Oliver Reich
Journal:  Eur Urol       Date:  2008-12-17       Impact factor: 20.096

10.  Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.

Authors:  Evanguelos Xylinas; Michael Rink; Vitaly Margulis; Thomas Clozel; Richard K Lee; Evi Comploj; Giacomo Novara; Jay D Raman; Yair Lotan; Alon Weizer; Morgan Roupret; Armin Pycha; Douglas S Scherr; Christian Seitz; Vincenzo Ficarra; Quoc-Dien Trinh; Pierre I Karakiewicz; Francesco Montorsi; Marc Zerbib; Shahrokh F Shariat
Journal:  BJU Int       Date:  2013-03-06       Impact factor: 5.588

View more
  14 in total

Review 1.  Gender differences in incidence and outcomes of urothelial and kidney cancer.

Authors:  Ilaria Lucca; Tobias Klatte; Harun Fajkovic; Michela de Martino; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2015-10       Impact factor: 14.432

2.  Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.

Authors:  Yen-Ting Wu; Hao Lun Luo; Hung Jen Wang; Yen Ta Chen; Yuan Tso Cheng; Po Hui Chiang
Journal:  Int Urol Nephrol       Date:  2020-01-29       Impact factor: 2.370

3.  The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study.

Authors:  Hsin-Chih Yeh; Chao-Hsiang Chang; Jen-Kai Fang; I-Hsuan Alan Chen; Jen-Tai Lin; Jian-Hua Hong; Chao-Yuan Huang; Shian-Shiang Wang; Chuan-Shu Chen; Chi-Wen Lo; Chih-Chin Yu; Jen-Shu Tseng; Wun-Rong Lin; Yeong-Chin Jou; Ian-Seng Cheong; Yuan-Hong Jiang; Chung-You Tsai; Thomas Y Hsueh; Yung-Tai Chen; Hsu-Che Huang; Yao-Chou Tsai; Wei-Yu Lin; Chia-Chang Wu; Po-Hung Lin; Te-Wei Lin; Wen-Jeng Wu
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

Review 4.  Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Thomas Seisen; Shahrokh F Shariat; Olivier Cussenot; Benoit Peyronnet; Raphaële Renard-Penna; Pierre Colin; Morgan Rouprêt
Journal:  World J Urol       Date:  2016-01-25       Impact factor: 4.226

Review 5.  Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma.

Authors:  Zine-Eddine Khene; Romain Mathieu; Solène-Florence Kammerer-Jacquet; Thomas Seisen; Morgan Roupret; Shahrokh F Shariat; Benoit Peyronnet; Karim Bensalah
Journal:  Transl Androl Urol       Date:  2016-10

6.  Prediction of high-grade ureteral urothelial carcinoma on CT urography.

Authors:  Hwang Sung Tae; Sung Deuk Jae; Yang Kyung Sook; Sim Ki Choon; Han Na Yeon; Park Beom Jin; Kim Min Ju; Cho Sung Bum
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

Review 7.  Risk stratification for upper tract urinary carcinoma.

Authors:  Daniel Benamran; Thomas Seisen; Elias Naoum; Christophe Vaessen; Jérome Parra; Pierre Mozer; Shahrokh F Shariat; Morgan Rouprêt
Journal:  Transl Androl Urol       Date:  2020-08

8.  The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.

Authors:  Ping Tan; Ming Shi; Jie Chen; Hang Xu; Nan Xie; Huan Xu; Yong Jiang; Jian-Zhong Ai; Liang-Ren Liu; Lu Yang; Qiang Wei
Journal:  Asian J Androl       Date:  2019 Mar-Apr       Impact factor: 3.285

Review 9.  Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up.

Authors:  Mudhar N Hasan; Morgan Rouprêt; Francis Keeley; Cecilia Cracco; Robert Jones; Michael Straub; Olivier Traxer; Palle Jörn Sloth Osther; Marianne Brehmer
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

10.  Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Yuejun Tian; Yuwen Gong; Yangyang Pang; Zhiping Wang; Mei Hong
Journal:  PeerJ       Date:  2016-06-21       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.